Page last updated: 2024-10-29

ifosfamide and Synovioma

ifosfamide has been researched along with Synovioma in 61 studies

Research Excerpts

ExcerptRelevanceReference
"Treatment with ifosfamide chemotherapy and palliative radiation therapy was effective in reducing the growth of the tumor in the pulmonary artery and pleural lesions, indicating that this regimen may be useful for the treatment of unresectable SS in the pulmonary artery."5.42Intravascular synovial sarcoma of the pulmonary artery with massive pleural effusion: report of a case with a favorable response to Ifosfamide chemotherapy and palliative radiation therapy. ( Atagi, S; Kawaguchi, T; Maekura, T; Matsui, H; Morimoto, M; Okuma, T; Shimizu, S, 2015)
" A novel five-drug combination of etoposide, vincristine, dactinomycin, ifosfamide, and doxorubicin (EVAIA) was evaluated for high-risk patients, but cumulative chemotherapy dosage and treatment duration were reduced for the remaining individuals as compared with that of the previous trial CWS-86."2.74Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults. ( Bielack, SS; Brecht, I; Dantonello, TM; Dickerhoff, R; Gadner, H; Greiner, J; Greulich, M; Harms, D; Herbst, M; Int-Veen, C; Juergens, H; Kirsch, S; Klingebiel, T; Koscielniak, E; Leuschner, I; Marky, I; Scheel-Walter, HG; Schmelzle, R; Schmidt, BF; Treuner, J, 2009)
"Primary laryngeal synovial sarcoma is an extremely rare tumor predominantly affecting young adults."2.72Laryngeal Synovial Sarcoma: A Systematic Review of the Last 40 Years of Reported Cases. ( Anazodo, A; Jacobson, I; Loo, C; Potter, A; Sandhu, G; Shein, G, 2021)
"Ifosfamide was infused at the dose of 2 g/m2 over a 4-hour bolus infusion, followed by 2-g/m2 24-hour continuous infusions of ifosfamide, for a total of 14 or 18 g/m2 (6-8 days)."2.67Synovial sarcoma. Uniform response of metastases to high dose ifosfamide. ( Eckardt, J; Eilber, F; Forscher, C; Fu, YS; Holmes, C; Lowenbraun, S; Rosen, G, 1994)
"Primary pericardial synovial sarcoma is a rare disease."2.50Pericardial synovial sarcoma: a case report and review of the literature. ( Hamada, H; Hiroshima, K; Kimura, S; Koh, E; Kume, Y; Saito, H; Sekine, Y; Wu, D; Yoshino, M, 2014)
"Synovial sarcoma is a malignant soft-tissue neoplasm, usually arising in close association with the joints and generally carrying a poor prognosis."2.43Bilateral metastatic renal synovial sarcoma. ( Matin, SF; Pollock, RE; Stage, AC, 2005)
"Synovial sarcoma is a unique tumor with substantial promise for biologically targeted therapy."2.43Diagnosis and management of synovial sarcoma. ( Albritton, KH; Hitchcock, Y; Joyner, DE; Randall, RL; Schabel, KL, 2005)
"Synovial sarcoma is a rare malignant tumor that typically originates from the soft tissue of the extremities."1.62Primary pharyngeal synovial sarcoma in a pediatric patient: A case report. ( Bae, YJ; Cha, W; Choi, BS; Kim, H, 2021)
"Treatment with ifosfamide chemotherapy and palliative radiation therapy was effective in reducing the growth of the tumor in the pulmonary artery and pleural lesions, indicating that this regimen may be useful for the treatment of unresectable SS in the pulmonary artery."1.42Intravascular synovial sarcoma of the pulmonary artery with massive pleural effusion: report of a case with a favorable response to Ifosfamide chemotherapy and palliative radiation therapy. ( Atagi, S; Kawaguchi, T; Maekura, T; Matsui, H; Morimoto, M; Okuma, T; Shimizu, S, 2015)
" A partial radiological response was achieved; dosage was reduced to 1."1.40Response to trabectedin in a patient with advanced synovial sarcoma with lung metastases. ( Basso, U; Maruzzo, M; Montesco, MC; Rastrelli, M; Roma, A; Zanardi, E, 2014)
"Multivariate analysis identified LN metastases (HR 6."1.39Factors influencing survival in metastatic synovial sarcoma: importance of patterns of metastases and the first-line chemotherapy regimen. ( Abu Sheikha, A; Al Mousa, A; Salah, S; Salem, A; Sultan, I; Yaser, S, 2013)
"Primary pleural synovial sarcoma is a rare disease with poor outcomes."1.36Radiological assessment following thermoradiation therapy for primary pleural synovial sarcoma: case report. ( Abe, K; Furuhashi, S; Maebayashi, T; Sakaguchi, M; Shizukuishi, T; Sugitani, M; Takahashi, M; Tanaka, Y; Uematsu, A, 2010)
"Synovial sarcoma is a chemosensitive soft tissue sarcoma."1.33Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital. ( Fisher, C; Judson, IR; Spurrell, EL; Thomas, JM, 2005)
"Retroperitoneal synovial sarcomas are very rare."1.33Retroperitoneal synovial sarcoma. ( Crişan, D; Domşa, I; Olinici, CD, 2006)
"Synovial sarcoma is an extremely rare primary pulmonary tumor whose description is based on a limited number of cases."1.32[Primary pulmonary synovial sarcoma: a report and diagnosis of 2 cases]. ( Baldo Padró, X; Bernadó Turmo, L; Haro Estarriol, M; Rubio Goday, M; Sebastián Quetglas, F; Viñas Villaró, G, 2003)
"The role and value of chemotherapy for soft tissue sarcomas remain unclear."1.30[Chemotherapy for pulmonary metastases of soft tissue sarcoma]. ( Kito, M; Umeda, T, 1998)

Research

Studies (61)

TimeframeStudies, this research(%)All Research%
pre-19901 (1.64)18.7374
1990's7 (11.48)18.2507
2000's25 (40.98)29.6817
2010's22 (36.07)24.3611
2020's6 (9.84)2.80

Authors

AuthorsStudies
Fiore, M1
Sambri, A1
Spinnato, P1
Zucchini, R1
Giannini, C1
Caldari, E1
Pirini, MG1
De Paolis, M1
Hagiwara, Y1
Iwata, S3
Ogura, K1
Kawai, A2
Susa, M1
Morioka, H1
Hiruma, T1
Tsuda, Y1
Kawano, H1
Yonemoto, T2
Ishii, T2
Okazaki, K1
Bae, YJ1
Kim, H1
Cha, W1
Choi, BS1
Moreau-Bachelard, C1
Campion, L1
Toulmonde, M1
Le Cesne, A1
Brahmi, M1
Italiano, A2
Mir, O1
Piperno-Neumann, S2
Laurence, V1
Firmin, N1
Penel, N1
Duffaud, F1
Chevreau, C1
Bertucci, F1
Narciso, B1
Dubray-Longeras, P1
Delcambre, C1
Saada-Bouzid, E1
Boudou-Rouquette, P1
Soulie, P1
Perrin, C1
Blay, JY2
Bompas, E1
Kojima, Y1
Shimoi, T1
Seo, T1
Yazaki, S1
Okuya, T1
Ohtake, Y1
Okuma, HS1
Shimomura, A1
Nishikawa, T1
Tanioka, M1
Sudo, K1
Noguchi, E1
Tamura, K1
Yoshida, A1
Kobayashi, E1
Fujiwara, Y1
Yonemori, K1
Yu, L1
Gu, T1
Desar, IME1
Fleuren, EDG1
van der Graaf, WTA1
Patrono, D1
Paraluppi, G1
Romagnoli, R1
Puj, KS1
Pandya, SJ1
Warikoo, V1
Chauhan, T1
Samanta, ST1
Shein, G1
Sandhu, G1
Potter, A1
Loo, C1
Jacobson, I1
Anazodo, A1
Salah, S1
Yaser, S1
Salem, A1
Al Mousa, A1
Abu Sheikha, A1
Sultan, I1
Yoshino, M1
Sekine, Y1
Koh, E1
Kume, Y1
Saito, H1
Kimura, S1
Hamada, H1
Wu, D1
Hiroshima, K1
Vakil, K1
Raza, A1
Zakharova, M1
Madlon-Kay, R1
Skubitz, K1
Patel, M1
Wakamatsu, T1
Naka, N1
Sasagawa, S1
Tanaka, T1
Takenaka, S1
Araki, N1
Ueda, T1
Nishizawa, Y1
Yoshikawa, H1
Itoh, K1
Chakiba, C1
Lagarde, P1
Pissaloux, D1
Neuville, A1
Brulard, C1
Pérot, G1
Coindre, JM1
Terrier, P1
Ranchere-Vince, D1
Ferrari, A2
Collini, P1
Suurmeijer, AJH1
Terrisse, SA1
Averous, G1
Bui, B1
Orbach, D1
Chibon, F1
Zanardi, E1
Maruzzo, M1
Montesco, MC1
Roma, A1
Rastrelli, M1
Basso, U1
Maekura, T1
Shimizu, S1
Kawaguchi, T2
Morimoto, M1
Okuma, T1
Matsui, H1
Atagi, S1
Grignani, G1
Martín-Broto, J1
Schuler, M1
Reichardt, P1
Sugitani, A1
Asai, K1
Kojima, K1
Eguchi, Y1
Ohsawa, M1
Hirata, K1
Takahashi, M2
Maru, M1
Tomioka, A1
Saito, M1
Araki, Y1
Tazaki, M1
Tsuchiya, M1
Kamoda, H1
Deme, D1
Abdulfatah, B1
Telekes, A1
Ford, ME1
Stevens, R1
Rosado-de-Christenson, ML1
Hall, NC1
Suster, S1
Mullah-Ali, A1
Ramsay, JA1
Bourgeois, JM1
Hodson, I1
Macdonald, P1
Midia, M1
Portwine, C1
Canter, RJ1
Qin, LX1
Maki, RG2
Brennan, MF2
Ladanyi, M1
Singer, S2
Dantonello, TM1
Int-Veen, C1
Harms, D1
Leuschner, I1
Schmidt, BF1
Herbst, M1
Juergens, H1
Scheel-Walter, HG1
Bielack, SS1
Klingebiel, T1
Dickerhoff, R1
Kirsch, S1
Brecht, I1
Schmelzle, R1
Greulich, M1
Gadner, H1
Greiner, J1
Marky, I1
Treuner, J1
Koscielniak, E1
Osanai, T1
Tsuchiya, T1
Sugawara, M1
Ptaszyński, K1
Szumera-Ciećkiewicz, A1
Zakrzewska, K1
Tuziak, T1
Mrozkowiak, A1
Rutkowski, P1
Abe, K1
Maebayashi, T1
Shizukuishi, T1
Sakaguchi, M1
Furuhashi, S1
Tanaka, Y1
Uematsu, A1
Sugitani, M1
Fekih, L1
Boussoffara, L1
Fenniche, S1
Abdelghaffar, H1
Akrout, I1
Ayadi, A1
Megdiche, ML1
Ozkan, EE1
Mertsoylu, H1
Ozardali, HI1
Chen, Y1
Yang, Y1
Wang, C1
Shi, Y1
Ouadnouni, Y1
Smahi, M1
Bouchikh, M1
Achir, A1
Msougar, Y1
Lakranbi, M1
Benosman, A1
De Salvo, GL1
Dall'Igna, P1
Meazza, C1
De Leonardis, F1
Manzitti, C1
De Ioris, MA1
Casanova, M1
Carli, M1
Bisogno, G1
Schoneveld, JM1
Debing, E1
Verfaillie, G1
Geers, C1
Van den Brande, P1
Haro Estarriol, M1
Baldo Padró, X1
Rubio Goday, M1
Sebastián Quetglas, F1
Viñas Villaró, G1
Bernadó Turmo, L1
Shirakawa, T1
Fujisawa, M1
Gotoh, A1
Okada, H1
Arakawa, S1
Kamidono, S1
Anand, AK1
Khanna, A1
Sinha, SK1
Mukherjee, U1
Walia, JS1
Singh, AN1
Park, SJ1
Kim, HK1
Kim, CK1
Park, SK1
Go, ES1
Kim, ME1
Hong, DS1
Hemmings, C1
Fisher, C2
Fletcher, DT1
Warner, WC1
Neel, MD1
Merchant, TE1
Van der Mieren, G1
Willems, S1
Sciot, R1
Dumez, H1
Van Oosterom, A1
Flameng, W1
Herijgers, P1
Kumar, S1
Chaudhry, MA1
Khan, I1
Duthie, DJ1
Lindsay, S1
Kaul, P1
Spurrell, EL1
Thomas, JM1
Judson, IR1
Stage, AC1
Pollock, RE1
Matin, SF1
Karadag, O1
Altundag, K1
Elkiran, ET1
Dikbas, O1
Gedikoglu, G1
Kars, A1
Eichelberger, L1
Jones, TD1
Vance, G1
Saxena, R1
Randall, RL1
Schabel, KL1
Hitchcock, Y1
Joyner, DE1
Albritton, KH1
Li, EX1
Zhang, YT1
Shang, JT1
Xu, Z1
Geng, Y1
Li, SM1
Shi, F1
Wu, YY1
Holloway, CL1
Russell, AH1
Muto, M1
Albert, M1
Viswanathan, AN1
Domşa, I1
Crişan, D1
Olinici, CD1
Eilber, FC1
Eilber, FR1
Eckardt, JJ1
Grobmyer, SR1
Riedel, E1
Forscher, C3
Bettendorf, O1
Bierer, S1
Köhler, G1
Piechota, HJ1
Mesters, RM1
Klockenbusch, W1
Shinozaki, T1
Matsushita, M1
Kusawake, H1
Watanabe, H1
Arita, S1
Chigira, M1
Udagawa, E1
Rosen, G2
Lowenbraun, S2
Eilber, F2
Eckardt, J2
Holmes, C1
Fu, YS1
Kampe, CE1
Foster, J1
Selch, M1
Saboorian, MH1
Ashfaq, R1
Vandersteenhoven, JJ1
Schneider, NR1
Debourdeau, P1
Gligorov, J1
Couteau, C1
Kito, M1
Umeda, T1
Lehrich, RW1
Moll, S1
Luft, FC1
Mullier, J1
Beauvois, S1
Gebhart, M1
Roelandts, M1
Van Houtte, P1
Boven, E1
Calame, JJ1
Molthoff, CF1
Pinedo, HM1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Randomised Phase-III Trial of the Cooperative Weichteilsarkom Study Group (CWS) for Localised High-risk Rhabdomyosarcoma and Localised Rhabdomyosarcoma-like Soft Tissue Sarcoma in Children, Adolescents, and Young Adults[NCT00876031]Phase 3195 participants (Actual)Interventional2009-07-01Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

8 reviews available for ifosfamide and Synovioma

ArticleYear
The Biology of Synovial Sarcoma: State-of-the-Art and Future Perspectives.
    Current treatment options in oncology, 2021, 10-23, Volume: 22, Issue:12

    Topics: Anthracyclines; Antineoplastic Agents; Chemotherapy, Adjuvant; Epigenomics; Gene Expression Regulati

2021
Systemic Treatment for Adults with Synovial Sarcoma.
    Current treatment options in oncology, 2018, 03-07, Volume: 19, Issue:2

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Humans; I

2018
Laryngeal Synovial Sarcoma: A Systematic Review of the Last 40 Years of Reported Cases.
    Ear, nose, & throat journal, 2021, Volume: 100, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Diagnosis, Differential; Female; Humans; Ifos

2021
Pericardial synovial sarcoma: a case report and review of the literature.
    Surgery today, 2014, Volume: 44, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cardiac Surgical Procedures; Chemotherap

2014
Paraspinal synovial sarcoma as an unusual postradiation complication in pediatric abdominal neuroblastoma.
    Journal of pediatric hematology/oncology, 2008, Volume: 30, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 18; Chromosomes, Human, X;

2008
A case of renal synovial sarcoma treated with adjuvant ifosfamide and doxorubicin.
    Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:15

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Doxorubicin; Female; H

2011
Bilateral metastatic renal synovial sarcoma.
    Urology, 2005, Volume: 65, Issue:2

    Topics: Amputation, Surgical; Antineoplastic Agents, Alkylating; Combined Modality Therapy; Female; Forearm;

2005
Diagnosis and management of synovial sarcoma.
    Current treatment options in oncology, 2005, Volume: 6, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Agents; Biomarkers, Tumor; Combined Modality Therapy; Doxorubicin;

2005

Trials

3 trials available for ifosfamide and Synovioma

ArticleYear
Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Mar-20, Volume: 27, Issue:9

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined

2009
Synovial sarcoma. Uniform response of metastases to high dose ifosfamide.
    Cancer, 1994, May-15, Volume: 73, Issue:10

    Topics: Adolescent; Adult; Female; Humans; Ifosfamide; Infusions, Parenteral; Lung Neoplasms; Male; Mesna; N

1994
Synovial sarcoma. A study of intensive chemotherapy in 14 patients with localized disease.
    Cancer, 1993, Oct-01, Volume: 72, Issue:7

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin

1993

Other Studies

50 other studies available for ifosfamide and Synovioma

ArticleYear
Clinical analysis of multimodal treatment for localized synovial sarcoma: A multicenter retrospective study.
    Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 2023, Volume: 28, Issue:1

    Topics: Chemotherapy, Adjuvant; Combined Modality Therapy; Humans; Ifosfamide; Retrospective Studies; Sarcom

2023
Primary pharyngeal synovial sarcoma in a pediatric patient: A case report.
    Medicine, 2021, Dec-30, Volume: 100, Issue:52

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Deglutition Disorders; Doxorubicin; Drug Resi

2021
Patterns of care and outcomes of 417 patients with METAstatic SYNovial sarcoma (METASYN): real-life data from the French Sarcoma Group (FSG).
    ESMO open, 2022, Volume: 7, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Child; Doxorubicin; Humans; Ifosf

2022
Poor Treatment Outcomes with Second-Line Chemotherapy in Advanced Synovial Sarcoma.
    Oncology, 2022, Volume: 100, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Humans; Ifosfamide; Retrosp

2022
Giant pericardial synovial sarcoma.
    Journal of cardiac surgery, 2017, Volume: 32, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Doxorubicin; Ech

2017
Disease-free survival after radical resection followed by adjuvant chemotherapy for primary hepatic synovial sarcoma.
    Updates in surgery, 2018, Volume: 70, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Epirubicin; Hepatectomy; Hum

2018
Primary Synovial Sarcoma of the Kidney: A Rare Presentation.
    Urology, 2018, Volume: 116

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Combined Modality The

2018
Factors influencing survival in metastatic synovial sarcoma: importance of patterns of metastases and the first-line chemotherapy regimen.
    Medical oncology (Northwood, London, England), 2013, Volume: 30, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Disease-Free Survival; Dox

2013
An absolute obstacle: cardiac metastasis of synovial sarcoma.
    The American journal of medicine, 2014, Volume: 127, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Deoxycytidine; Disease Progressi

2014
Deflection of vascular endothelial growth factor action by SS18-SSX and composite vascular endothelial growth factor- and chemokine (C-X-C motif) receptor 4-targeted therapy in synovial sarcoma.
    Cancer science, 2014, Volume: 105, Issue:9

    Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Bevacizumab; Cell Line, Tumor;

2014
Response to chemotherapy is not related to chromosome instability in synovial sarcoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2014, Volume: 25, Issue:11

    Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Chromosomal Instability; Female; Genome, Human; Hu

2014
Response to trabectedin in a patient with advanced synovial sarcoma with lung metastases.
    Anti-cancer drugs, 2014, Volume: 25, Issue:10

    Topics: Adult; Antineoplastic Agents; Axilla; Combined Modality Therapy; Dioxoles; Epirubicin; Fatal Outcome

2014
Intravascular synovial sarcoma of the pulmonary artery with massive pleural effusion: report of a case with a favorable response to Ifosfamide chemotherapy and palliative radiation therapy.
    Internal medicine (Tokyo, Japan), 2015, Volume: 54, Issue:9

    Topics: Adult; Antineoplastic Agents, Alkylating; Female; Humans; Ifosfamide; Oncogene Proteins, Fusion; Ple

2015
Trabectedin clinical cases: use according to indication in diverse clinical scenarios.
    Future oncology (London, England), 2015, Volume: 11, Issue:11 Suppl

    Topics: Anthracyclines; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; C

2015
Primary Pleural Synovial Sarcoma Treated with Pazopanib.
    Internal medicine (Tokyo, Japan), 2015, Volume: 54, Issue:16

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chest Pain; Doxorubicin; Dyspnea; Fatal Outco

2015
Marriage and fertility in long-term survivors of childhood, adolescent and young adult (AYA) high-grade sarcoma.
    International journal of clinical oncology, 2016, Volume: 21, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols

2016
[Synovial sarcoma. Case report].
    Orvosi hetilap, 2016, Feb-07, Volume: 157, Issue:6

    Topics: Abdominal Wall; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant;

2016
Rebound thymic hyperplasia after pneumonectomy and chemotherapy for primary synovial sarcoma.
    Journal of thoracic imaging, 2008, Volume: 23, Issue:3

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Humans; I

2008
A synovial sarcoma-specific preoperative nomogram supports a survival benefit to ifosfamide-based chemotherapy and improves risk stratification for patients.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Dec-15, Volume: 14, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Female; Humans; Ifosf

2008
Rapid pain relief and marked sclerotic change of multiple bone metastases from a synovial sarcoma after treatment with intravenous pamidronate and chemotherapy.
    Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 2009, Volume: 14, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neopla

2009
Her2, EGFR and TOPIIA gene amplification and protein expression in synovial sarcoma before and after combined treatment.
    Polish journal of pathology : official journal of the Polish Society of Pathologists, 2009, Volume: 60, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Agents; Combined Modality Therapy; DNA Topoisomerases, Type II; DN

2009
Radiological assessment following thermoradiation therapy for primary pleural synovial sarcoma: case report.
    Medical oncology (Northwood, London, England), 2010, Volume: 27, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Combined Modality Therapy; Cyclop

2010
[Rare primary chest wall sarcoma: the synovialosarcoma].
    Revue des maladies respiratoires, 2011, Volume: 28, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chest Pain; Combined

2011
Adjuvant chemotherapy decreases and postpones distant metastasis in extremity stage IIB/III synovial sarcoma patients.
    Journal of surgical oncology, 2012, Aug-01, Volume: 106, Issue:2

    Topics: Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant;

2012
[A rare tumor of the chest wall: the synovial sarcoma].
    The Pan African medical journal, 2011, Volume: 9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chest Pain; Comb

2011
Salvage rates and prognostic factors after relapse in children and adolescents with initially localised synovial sarcoma.
    European journal of cancer (Oxford, England : 1990), 2012, Volume: 48, Issue:18

    Topics: Adolescent; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemo

2012
Deep venous thrombosis and pulmonary embolism caused by an intravascular synovial sarcoma of the common femoral vein.
    Vascular and endovascular surgery, 2012, Volume: 46, Issue:8

    Topics: Adult; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Blood Vessel Prosthesis Impla

2012
[Primary pulmonary synovial sarcoma: a report and diagnosis of 2 cases].
    Archivos de bronconeumologia, 2003, Volume: 39, Issue:3

    Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherap

2003
Complete resection of synovial sarcoma of prostatic fascia.
    Urology, 2003, Volume: 61, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Doxorubicin; Humans; Ifosfam

2003
Pericardial synovial sarcoma.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2003, Volume: 15, Issue:4

    Topics: Adult; Antineoplastic Agents, Alkylating; Combined Modality Therapy; Dacarbazine; Heart Neoplasms; H

2003
A case of renal synovial sarcoma: complete remission was induced by chemotherapy with doxorubicin and ifosfamide.
    The Korean journal of internal medicine, 2004, Volume: 19, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Humans; Ifosfamide; Kidn

2004
Primary omental synovial sarcoma: a case with cytogenetic confirmation.
    Pathology, 2004, Volume: 36, Issue:2

    Topics: Adult; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; D

2004
Valgus and varus deformity after wide-local excision, brachytherapy and external beam irradiation in two children with lower extremity synovial cell sarcoma: case report.
    BMC cancer, 2004, Aug-27, Volume: 4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brachytherapy; Chemotherapy, Adjuvant; Child

2004
Pericardial synovial sarcoma: 14-year survival with multimodality therapy.
    The Annals of thoracic surgery, 2004, Volume: 78, Issue:3

    Topics: Adult; Chemotherapy, Adjuvant; Dimethoate; Disease Progression; Doxorubicin; Drug Administration Sch

2004
Metastatic left atrial synovial sarcoma mimicking a myxoma.
    The Journal of thoracic and cardiovascular surgery, 2004, Volume: 128, Issue:5

    Topics: Adult; Antineoplastic Agents, Alkylating; Combined Modality Therapy; Diagnosis, Differential; Heart

2004
Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:3

    Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Doxorubicin; Fem

2005
Anterior abdominal wall synovial sarcoma: a rare presentation.
    American journal of clinical oncology, 2005, Volume: 28, Issue:3

    Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Chemotherapy,

2005
A 37-year-old man with a pleural mass.
    Archives of pathology & laboratory medicine, 2005, Volume: 129, Issue:8

    Topics: Adult; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Chemotherapy, Adjuvant; Chromosomes, Hu

2005
[Effect of modified MAID regimen for patients with advanced soft tissue sarcoma].
    Ai zheng = Aizheng = Chinese journal of cancer, 2006, Volume: 25, Issue:8

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; F

2006
Synovial cell sarcoma of the vulva: multimodality treatment incorporating preoperative external-beam radiation, hemivulvectomy, flap reconstruction, interstitial brachytherapy, and chemotherapy.
    Gynecologic oncology, 2007, Volume: 104, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Chemotherapy, Adjuvant; Combined Moda

2007
Retroperitoneal synovial sarcoma.
    Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie, 2006, Volume: 47, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Humans; Ifosfamide;

2006
Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma.
    Annals of surgery, 2007, Volume: 246, Issue:1

    Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Arm; Diseas

2007
Neoplasia of the kidney--a rare event during pregnancy: part 2.
    European urology, 2006, Volume: 50, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Femal

2006
[Combination effect of pirarubicin, ifosfamide, and vincristine sulfate in the treatment of advanced synovial sarcoma--report of a case].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Buttocks; Cystitis; Doxorubicin; Female; Hemo

1995
Cytogenetics as an adjunct in establishing a definitive diagnosis of synovial sarcoma by fine-needle aspiration.
    Cancer, 1997, Jun-25, Volume: 81, Issue:3

    Topics: Adult; Biopsy, Needle; Cytogenetics; Diagnosis, Differential; DNA, Neoplasm; Humans; Ifosfamide; Kar

1997
Genetic abnormalities in synovial sarcoma.
    The New England journal of medicine, 1998, Jun-04, Volume: 338, Issue:23

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Disease-Free Survival; Doxor

1998
[Chemotherapy for pulmonary metastases of soft tissue sarcoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:11

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administra

1998
Evaluating a critically ill patient with metabolic acidosis: the ifosfamide paradigm.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1999, Volume: 14, Issue:1

    Topics: Acidosis; Acidosis, Renal Tubular; Antineoplastic Combined Chemotherapy Protocols; Carbon Dioxide; C

1999
[Pigmented villonodular synovitis: apropos of 3 cases].
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2001, Volume: 5, Issue:2

    Topics: Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Arthroplasty, Replaceme

2001
Characterization and chemotherapy of human soft tissue sarcoma (STS) lines grown in nude mice.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1989, Volume: 165, Issue:7

    Topics: Animals; Cyclophosphamide; Doxorubicin; Female; Fibrosarcoma; Histiocytoma, Benign Fibrous; Humans;

1989